logo
Book a meeting
ORCOSA

Orcosa

Biotechnology, 7 Graphics Dr, Ewing, New Jersey, 08628, United States, 11-50 Employees

orcosa.com

  • twitter
  • LinkedIn

Who is ORCOSA

A life sciences company modernizing the way medicines are taken. Our mission is to improve patient outcomes through our next generation therapeutic delivery system, the Rapid Infusion Tec...

Read More

lock icon Get Full Access
map
  • 7 Graphics Dr, Ewing, New Jersey, 08628, United States Headquarters: 7 Graphics Dr, Ewing, New Jersey, 08628, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from ORCOSA

ORCOSA Org Chart and Mapping

Employees
Lauren Bartlett

Lauren Bartlett

Head of Business Administration

Mark Ridall

Mark Ridall

Chairman of the Board of Directors

Robert Pollaro

Robert Pollaro

Executive Vice President and Chief Legal Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for ORCOSA
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding ORCOSA

Answer: ORCOSA's headquarters are located at 7 Graphics Dr, Ewing, New Jersey, 08628, United States

Answer: ORCOSA's official website is https://orcosa.com

Answer: ORCOSA's revenue is Under $1 Million

Answer: ORCOSA has 11-50 employees

Answer: ORCOSA is in Biotechnology

Answer: ORCOSA contact info: Phone number: Website: https://orcosa.com

Answer: A life sciences company modernizing the way medicines are taken. Our mission is to improve patient outcomes through our next generation therapeutic delivery system, the Rapid Infusion Technology (RITeTM) Platform, a fast acting, easy-to-take tablet engineered to enhance drug absorption. With our proprietary manufacturing processes and state of the art cGMP-compliant facility in the U.S., we have developed our first product candidate, ORAVEXXTM, a non-addictive proprietary cannabidiol composition that utilizes the RITeTM Platform to treat pain and provide a safe, alternative treatment option to opioids. We are empowering the medical community by partnering with leading research institutions and physicians to support multiple FDA-authorized investigator-initiated clinical trials that utilize the RITeTM Platform to determine the safety and efficacy of CBD for the management of pain and inflammation.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access